Benz Sciences Inc.
PrivateLast Round
Corporate Funding
Jun 2, 2025
Company Overview
Benz Sciences Inc. is a clinical-stage biopharmaceutical company that specializes in drug discovery and development, specifically focusing on the development of the LSD1 inhibitor TAS1440.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
biopharmaceuticalLSD1 inhibitormyeloproliferative neoplasmsclinical-stage biotechdrug developmenthematological oncologysmall-molecule drugtherapeutic candidatein-licensingspecial purpose vehiclebiotech startupcancer drug pipeline
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Benz Sciences Inc. Comparables
Compare Benz Sciences Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Merck & Co., Inc. | 81% | |
| Decoy Therapeutics | 77% | |
| Recursion Pharmaceuticals | 75% | |
Benz Sciences Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Jun 2, 2025 |
Benz Sciences Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Benz Sciences Inc.'s valuation, stock price, and market status.